'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41264705.
- Also identified by DOI 10.1126/science.aee0352.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ganaplacide, developed by Novartis, eases worries about drug resistance-but hard choices loom on how to use it.
Medical subject headings
- Antimalarials
- Malaria
- Malaria, Falciparum
- Plasmodium falciparum
- Imidazoles
- Piperazines
- Drug Development